Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

333 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The presence of intraductal carcinoma of the prostate in needle biopsy is a significant prognostic factor for prostate cancer patients with distant metastasis at initial presentation.
Kato M, Tsuzuki T, Kimura K, Hirakawa A, Kinoshita F, Sassa N, Ishida R, Fukatsu A, Kimura T, Funahashi Y, Matsukawa Y, Hattori R, Gotoh M. Kato M, et al. Among authors: funahashi y. Mod Pathol. 2016 Feb;29(2):166-73. doi: 10.1038/modpathol.2015.146. Epub 2016 Jan 8. Mod Pathol. 2016. PMID: 26743470 Free article.
Integrating tertiary Gleason pattern 5 into the ISUP grading system improves prediction of biochemical recurrence in radical prostatectomy patients.
Kato M, Hirakawa A, Kobayashi Y, Yamamoto A, Ishida R, Kamihira O, Kimura T, Majima T, Ishida S, Funahashi Y, Sassa N, Fujita T, Matsukawa Y, Yamamoto T, Hattori R, Gotoh M, Tsuzuki T. Kato M, et al. Among authors: funahashi y. Mod Pathol. 2019 Jan;32(1):122-127. doi: 10.1038/s41379-018-0121-8. Epub 2018 Sep 4. Mod Pathol. 2019. PMID: 30181565 Free article.
The influence of the presence of intraductal carcinoma of the prostate on the grade group system's prognostic performance.
Kato M, Hirakawa A, Kobayashi Y Ms, Yamamoto A, Ishida R, Sano T, Kimura T, Majima T, Ishida S, Funahashi Y, Sassa N, Fujita T, Matsukawa Y, Yamamoto T, Hattori R, Gotoh M, Tsuzuki T. Kato M, et al. Among authors: funahashi y. Prostate. 2019 Jul;79(10):1065-1070. doi: 10.1002/pros.23818. Epub 2019 Apr 26. Prostate. 2019. PMID: 31025722
Response of intraductal carcinoma of the prostate to androgen deprivation therapy predicts prostate cancer prognosis in radical prostatectomy patients.
Kato M, Hirakawa A, Kobayashi Y, Yamamoto A, Ishida R, Kamihira O, Sano T, Majima T, Ishida S, Funahashi Y, Sassa N, Fujita T, Matsukawa Y, Hattori R, Gotoh M, Tsuzuki T. Kato M, et al. Among authors: funahashi y. Prostate. 2020 Feb;80(3):284-290. doi: 10.1002/pros.23942. Epub 2019 Dec 20. Prostate. 2020. PMID: 31860754
Effect of core needle biopsy number on intraductal carcinoma of the prostate (IDC-P) diagnosis in patients with metastatic hormone-sensitive prostate cancer.
Kato M, Hirakawa A, Kobayashi Y, Yamamoto A, Naito Y, Tochigi K, Sano T, Ishida S, Funahashi Y, Fujita T, Matsukawa Y, Hattori R, Tsuzuki T. Kato M, et al. Among authors: funahashi y. Int J Clin Oncol. 2020 Dec;25(12):2130-2137. doi: 10.1007/s10147-020-01756-0. Epub 2020 Aug 3. Int J Clin Oncol. 2020. PMID: 32748295
Grade group 2 (10% ≥ GP4) patients have very similar malignant potential with grade group 1 patients, given the risk of intraductal carcinoma of the prostate.
Kato M, Hirakawa A, Sato H, Hanazawa R, Naito Y, Tochigi K, Sano T, Ishida S, Funahashi Y, Fujita T, Matsukawa Y, Hattori R, Tsuzuki T. Kato M, et al. Among authors: funahashi y. Int J Clin Oncol. 2021 Apr;26(4):764-769. doi: 10.1007/s10147-020-01841-4. Epub 2021 Jan 1. Int J Clin Oncol. 2021. PMID: 33385274
333 results